|Bid||0.8600 x 0|
|Ask||0.9200 x 0|
|Day's Range||0.8500 - 0.8800|
|52 Week Range||0.6200 - 1.0500|
|Beta (3Y Monthly)||0.68|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 11, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.90|
QUEBEC CITY , July 16, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OTCQX: OPSSF) today announced that Opsens Solutions Inc. ("Opsens Solutions"), its wholly-owned subsidiary, has received an order for more than a hundred fiber optic sensors and systems, to be deployed in a new dewatering process of oil sands tailings. The order was placed by ElectroKinetic Solutions, a company that has developed an innovative process which allows large volumes of tailing deposits to be dewatered rapidly with substantially lower energy requirements than conventional processes. Opsens Solutions will provide fiber optic monitoring systems and sensors that will optimize the dewatering operations to prevent negative impacts on the environment. "Our fiber optic technology can be adapted to measure various parameters in the most difficult conditions to deliver significant benefits in terms of process optimization and risk reduction to the environment and health, which are compelling sales arguments for many industries," said Gaétan Duplain, President of Opsens Solutions.
I've been keeping an eye on Opsens Inc. (TSE:OPS) because I'm attracted to its fundamentals. Looking at the company as...
Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OTCQX:OPSSF) today announced that Opsens Solutions Inc. ("Opsens Solutions"), its wholly-owned subsidiary, is partnering with Temai Ingenieros S.L. ("Temai") for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. This agreement comes after over a year of development and ground testing of an aircraft fuel monitoring system based on Opsens Solutions’ fiber optic sensing technology.
QUEBEC CITY , June 11, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) today announced that its wholly-owned subsidiary Opsens Solutions Inc. ("Opsens Solutions"), has been granted a patent for an innovative optical-based pressure sensor from the United States Patent and Trademark Office ("USPTO"). Patent no. 10,082,437 entitled "Optical Pressure Sensor with Reduced Mechanical Stresses" describes an innovative fiber optic pressure sensor design aimed at solving sensor drift, one of the most challenging problems encountered with sensors used in high pressure environments. Tested by a world-renowned, independent laboratory, this new fiber optic pressure sensor has shown unparalleled low-drift performances when measuring minute changes in differential pressure.
QUEBEC CITY, QC / ACCESSWIRE / May 22, 2019 / Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) ( OTCQX: OPSSF ) , a company focusing mainly on physiological measurements such as Fractional ...
QUEBEC CITY , April 30, 2019 /CNW Telbec/ - Opsens inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) is pleased to announce it has entered into a supply agreement as part of its long-term collaboration with Abiomed, Inc. ("Abiomed") for the Impella CP® heart pump. Abiomed has awarded Opsens a five-year agreement to supply a critical component for its heart pump technology. This new agreement between Opsens and Abiomed follows a co-development and license agreement to integrate Opsens' miniature optical pressure sensor into Impella CP® heart pumps, signed in 2014.
If you own shares in Opsens Inc. (TSE:OPS) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Volatility is considered to be a measure of ris...
QUEBEC CITY , March 4, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.TO) (OPSSF) is pleased to announce the appointment of Mr. Alan Milinazzo as Executive Chairman of the Board of Directors. "We are delighted to see Alan, a renowned leader in the medical device industry, join us. Alan has had extensive success in building high-performance commercial teams in interventional cardiology.
QUEBEC CITY , Feb. 27, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.TO) (OPSSF) is pleased to announce that it has entered into an $8 M credit agreement (the "Agreement") with CIBC Innovation Banking (CIBC). "The Agreement offered carries excellent conditions. The Agreement consists of a $7 M term loan, set to mature in 60 months and of a $1 M revolving operating credit margin, set to mature in one year and that may be renewed on an annual basis.
Opsens Inc.'s (TSE:OPS): Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. With the latest financialRead More...
NEW YORK, NY / ACCESSWIRE / January 14, 2019 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us ...
QUEBEC CITY , Jan. 9, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) has been granted CE marking for its diastolic pressure algorithm ("dPR"). Opsens' dPR algorithm has been designed to assess intracoronary pressure with the heart at rest to diagnose coronary disease without the injection of heart-stimulating medication. Opsens' diastolic pressure ratio will work in combination with the OptoWire and the OptoMonitor.
Louis Laflamme has been the CEO of Opsens Inc. (TSE:OPS) since 2013. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar Read More...
NEW YORK, NY / ACCESSWIRE / November 30, 2018 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us ...
QUEBEC CITY , Nov. 27, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.TO) (OPSSF) announced today that it has obtained approval from Health Canada to market its dPR Proprietary Resting Index, which measures intracoronary pressure and establishes a diagnosis with the heart at rest to guide the treatment of patients with coronary heart disease. The measurement of Fractional Flow Reserve ("FFR") as a method of assessing intracoronary pressure is now the gold standard among medical professionals and has gained credibility and popularity following the publication of clinical studies demonstrating better clinical outcomes. Opsens' dPR has been developed to meet the demand by cardiologists for a way to measure intracoronary pressure with the heart at rest.
The big shareholder groups in Opsens Inc (TSE:OPS) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership Read More...